Herd immunity to vaccine preventable infections in Saint Petersburg and the Leningrad region: serological status of measles, mumps, and rubella

A. Yu. Popova; Попова А. Ю.; S. A. Egorova; Егорова С. А.; Vyacheslav S. Smirnov; Смирнов Вячеслав Сергеевич; E. B. Ezhlova; Ежлова Е. Б.; A. M. Milichkina; Миличкина А. М.; A. A. Melnikova; Мельникова А. А.; N. S. Bashketova; Башкетова Н. С.; O. A. Istorik; Историк О. А.; L. V. Buts; Буц Л. В.; E. S. Ramsay; Рэмзи Э. С.; I. V. Drozd; Дрозд И. В.; O. B. Zhimbaeva; Жимбаева О. Б.; V. G. Drobyshevskaya; Дробышевская В. Г.; E. M. Danilova; Данилова Е. М.; V. A. Ivanov; Иванов В. А.; Areg A. Totolian; Тотолян Арег А.

doi:10.15789/2220-7619-HIT-17797

Herd immunity to vaccine preventable infections in Saint Petersburg and the Leningrad region: serological status of measles, mumps, and rubella

作者: Popova A.Y.¹, Egorova S.A.², Smirnov V.S.², Ezhlova E.B.¹, Milichkina A.M.², Melnikova A.A.¹, Bashketova N.S.³, Istorik O.A.⁴, Buts L.V.⁴, Ramsay E.S.², Drozd I.V.², Zhimbaeva O.B.², Drobyshevskaya V.G.², Danilova E.M.², Ivanov V.A.², Totolian A.A.²
隶属关系:
1. Federal Service for Supervision of Consumer Rights Protection and Human Wellbeing
2. St. Petersburg Pasteur Institute
3. Rospotrebnadzor Office for St. Petersburg
4. Rospotrebnadzor Office for Leningrad Region
期: 卷 14, 编号 6 (2024)
页面: 1187-1208
栏目: ORIGINAL ARTICLES
URL: https://journal-vniispk.ru/2220-7619/article/view/283038
DOI: https://doi.org/10.15789/2220-7619-HIT-17797
ID: 283038

如何引用文章

全文:

详细
全文:
作者简介
参考
补充文件
统计

详细

Specific measles, mumps, and rubella prevention has been the main prerequisite for a striking decline in the incidence of such infections in Russia. An increase in the percentage of seronegative individuals observed in recent years resulted in higher measles incidence being directly related to low herd immunity that accounts for a population protection solely under conditions of a high density of immunized individuals and their uniform distribution in the population. The number of immunized individuals may be estimated only while conducting seroepidemiological monitoring of herd immunity. The objective of the study was to assess a level of herd immunity in the St. Petersburg and Leningrad Region population against measles, mumps, and rubella viruses. Materials and methods. There were enrolled 6774 residents into the study: volunteers aged from 1 to 70+ years. The representativeness of the surveyed cohort was ensured by using the Web application “Monitoring of herd immunity against socially significant infections”, used at the stage of volunteer enrollment, by randomization and regulation of the sample size in age groups. Participants filled out a questionnaire and agreed to provide venous blood samples to assess IgG antibody levels against measles, mumps, and rubella viruses by using ELISA. Results. In September 2023, in St. Petersburg and the Leningrad Region, herd immunity met the criterion for epidemiological well-being only with respect to rubella. In all age groups, the proportion of seronegative individuals did not exceed 15%, and most volunteers had high Ab levels, both after illness and vaccination. For measles and mumps, the criterion for epidemiological well-being is considered not to exceed more than 7% seronegative individuals. A sufficient level of measles seroprevalence was detected only in older age groups (≥ 60 years old). Sufficient mumps seroprevalence was not detected in any age group. The average population (St. Petersburg, Leningrad Region) seroprevalence magnitude for measles, rubella, and mumps viruses were 81.4%, 95.5%, and 78.4%, respectively. The problematic age groups with low measles seroprevalence (62.4–74.3%) were adolescents (12–17 years) and young adults (18–39 years). Most seropositive individuals vaccinated against measles had low Ab levels; high levels were noted mainly in older measles convalescent individuals. Low mumps seroprevalence (~70%) was more often observed among adults aged 18 to 49 years. The distribution of seroprevalence in various occupational group was relatively uniform, with some predominance of seropositivity among pensioners and schoolchildren. Conclusion. The system of specific prophylaxis for vaccine-preventable viral infections used in Russia has shown high efficacy and contributed to the formation of herd immunity, which for many years allowed to lower a risk of both sporadic and group infections to minimal levels. Currently, measles and mumps seroprevalence in the local population is maintained at insufficient level to ensure epidemiological well-being. This necessitates making appropriate management decisions and conducting additional preventive measures aimed at enhancing relevant herd immunity.

关键词

vaccine-preventable infections, herd immunity, measles, rubella, mumps, seroprevalence, antibodies, St. Petersburg, Leningrad Region, population, cohort study

全文:

RAS Full Member, DSc (Medicine), Professor, Director

俄罗斯联邦, St. Petersburg

参考

Беляков Н.А., Трофимова Т.Н., Кулагина Е.Н., Митюрин Д.В., Соколов А.Р., Тучапский А.К., Фирсов В.В., Шелаев Ю.Б., Шелаева Е.П. По следам мировых эпидемий. От юстиниановой чумы до новой коронавирусной инфекции. СПб.: Лики. 2021. 296 с. [Belyakov N.A., Trofimova T.N., Kulagina E.N., Mityurin D.V., Sokolov A.R., Tuchapskii A.K., Firsov V.V., Shelaev Yu.B., Shelaeva E.P. In the footsteps of the world’s epidemics. From Justinian plague to a new coronavirus infection. St. Petersburg: Liki, 2021. 296 p. (In Russ.)]
Бинятова А.С., Унасова Т.Н., Илиасова Т.Н., Саркисян К.А., Фадейкина О.В., Мовсесянц А.А. Анализ качества комбинированной отечественной вакцины для профилактики кори, краснухи и эпидемического паротита // Вопросы вирусологии. 2022. Т. 67, № 5. С. 414–422. [Binyatova A.S., Unasova T.N., Iliasova T.N., Sargsyan K.A., Fadeikina O.V., Movsesyants A.A. Analysis of the quality of a combined domestic vaccine for the prevention of measles, rubella and mumps. Voprosy virusologii = Problems of Virology, 2022, vol. 67, no. 5, pp. 414–422. (In Russ.)] doi: 10.36233/0507-4088-131
Гринчик П.Р., Намазова-Баранова Л.С., Федосеенко М.В., Гирина А.А., Ковалев С.В., Мазоха А.В., Макушина Е.Д., Малинина Е.И., Мусихина А.Ю., Перминова О.А., Пленсковская Н.Ю., Привалова Т.Е., Ртищев А.Ю., Русинова Д.С., Рычкова О.А., Семериков В.В., Фоминых М.В., Фуголь Д.С., Якимова Н.В. Сравнительный анализ показателей привитости и охвата иммунизацией детского населения на территории федеральных округов Российской Федерации // Педиатрическая фармакология. 2022. Т. 19, № 1. С. 6–19. [Grinchik P.R., Namazova-Baranova L.S., Fedoseenko M.V., Girina A.A., Kovalev S.V., Mazokha A.V., Makushina E.D., Malinina E.I., Musikhina A.Y., Perminova O.A., Plenskovskaya N.Y., Privalova T.E., Rtishchev A.Y., Rusinova D.S., Rychkova O.A., Semerikov V.V., Fominykh M.V., Fugol D.S., Yakimova N.V. Comparative analysis of vaccination rates and immunization coverage of the pediatric population in Russian federal districts. Pediatricheskaya farmakologiya = Pediatric Pharmacology, 2022, vol. 19, no. 1, pp. 6–19. (In Russ.)] doi: 10.15690/pf.v18i6.2351
Загарьянц А.И., Яковлева И.В., Селезнева Т.С., Свиридов В.В., Белевская А.А. Длительность и напряженность поствакцинального гуморального иммунитета к вирусам кори, паротита и краснухи // Эпидемиология и вакцинопрофилактика. 2005. №. 5. С. 15–19. [Zagar’yants A.I., Yakovleva I.V., Selezneva T.S., Sviridov V.V., Belevskaya A.A. Duration and intensity of post-vaccination humoral immunity to measles, mumps and rubella viruses. Epidemiologiya i vaktsinoprofilaktika = Epidemiology and Vaccine Prophylaxis, 2005, no. 5, pp. 15–19. (In Russ.)]
Калькуляторы Radar. [Radar-research calculators]. URL: https://radar-research.ru/instruments/calculators (04.29.2024)
Крамарь Л.В., Каплунов К.О., Ларина Т.Ю., Морозова Д.Ю. Вакцинопрофилактика коклюша: реалии и ближайшие перспективы // Лекарственный вестник. 2018. Т. 72, № 4. С. 41–47. [Kramar L.V., Kaplunov K.O., Larina T.Yu., Morozova D.Yu. Vaccination against whooping cough: realities and immediate prospects. Lekarstvennyy vestnik = Medicinal Bulletin, 2018, vol. 72, no. 4, pp. 41–47. (In Russ.)]
Лаврентьева И.Н., Бичурина М.А., Антипова А.Ю., Камара Ж., Хоанг М., Банчевич М.Д., Железнова Н.В., Егорова С.А., Тотолян А.А. Коллективный иммунитет к вирусу краснухи в некоторых географических регионах // Инфекция и иммунитет. 2022. Т. 12, № 5. C. 902–908. [Lavrentyeva I.N., Bichurina M.A., Antipova A.Yu., Camara J., Hoang M., Banchevich M.D., Zheleznova N.V., Egorova S.A., Totolian A.A. Herd immunity to rubella virus in several geographic regions. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2022, vol. 12, no. 5, pp. 902–908. (In Russ.)] doi: 10.15789/2220-7619-AHI-2015.
Медицинская статистика. [Medical Statistics]. URL: https://medstatistic.ru (15.04.2024)
Ноздрачева А.В., Грицик А.А., Кузин С.Н., Семененко Т.А. Оценка фактической восприимчивости отдельных групп декретированного населения к вирусам кори, краснухи и эпидемического паротита // Вестник РГМУ. 2017. № 5. С. 58–62. [Nozdracheva A.V., Gritsik A.A., Kuzin S.N., Semenenko T.A. Assessment of the actual susceptibility of individual groups of the decreed population to measles, rubella and mumps viruses. Vestnik RGMU = Bulletin of RSMU, 2017, no. 5, pp. 58–62. (In Russ.)]
Ноздрачева А.В., Семененко Т.А. Состояние популяционного иммунитета к кори в России: систематический обзор и метаанализ эпидемиологических исследований // Журнал микробиологии, эпидемиологии и иммунобиологии. 2020. Т. 97, № 5. С. 445–457. [Nozdracheva A.V., Semenenko T.A. The state of collective immunity to measles in Russia: a systematic review and meta-analysis of epidemiological studies. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2020, vol. 97, no. 5, pp. 445–457. (In Russ.)] doi: 10.36233/0372-9311-2020-97-5-7
Ноздрачева А.В., Семененко Т.А., Русакова Е.В., Гусева Е.В., Иванова М.Ю., Готвянская Т.П. Состояние популяционного иммунитета к вирусам кори, краснухи и эпидемического паротита у населения Москвы в 2016–2017 гг. // Эпидемиология и инфекционные болезни. Актуальные вопросы. 2019. Т. 9, № 2. С. 31–38. [Nozdracheva A.V., Semenenko T.A., Rusakova E.V., Guseva E.V., Ivanova M.Y., Gotvyanskaya T.P. State of collective immunity to measles, rubella and mumps viruses in the Moscow population, 2016–2017. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy = Epidemiology and Infectious Diseases. Current Items, 2019, vol. 9, no. 2, pp. 31–38. (In Russ.)] doi: 10.18565/epidem.2019.9.2.31-8
Попова А.Ю., Тотолян А.А. Методология оценки популяционного иммунитета к вирусу SARS-CoV-2 в условиях пандемии COVID-19 // Инфекция и иммунитет. 2021. Т. 11, № 4. С. 609–616. [Popova A.Yu., Totolian A.A. Methodology for assessing collective immunity to the SARS-CoV-2 virus in the context of the COVID-19 pandemic. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2021, vol. 11, no. 4, pp. 609–616. (In Russ.)] doi: 10.15789/2220-7619-MFA-1770
Об утверждении национального календаря профилактических прививок, календаря профилактических прививок по эпидемическим показаниям и порядка проведения профилактических прививок: Приказ МЗ РФ от 06.12.2021 г. № 1122н. [On approval of the national calendar of preventive vaccinations, the calendar of preventive vaccinations for epidemiological indications and the procedure for conducting preventive vaccinations: Order of the Ministry of health of the Russian Federation of December 06, 2021, No. 1122N]. URL: https://normativ.kontur.ru/document?moduleId=1&documentId=410331 (12.06.2024)
Об утверждении национального календаря профилактических прививок и календаря профилактических прививок по эпидемическим показаниям: Приказ МЗ РФ от 21.03.2014 года № 125н. [About the approval of the national calendar of preventive vaccinations and the calendar of preventive vaccinations on epidemic indications: Order of the Ministry of health of the Russian Federation of March 21, 2014, No. 125n]. URL: https://normativ.kontur.ru/document?moduleId=1&documentId=379483#l0 (12.06.2024)
Об утверждении порядка организации и осуществления профилактики неинфекционных заболеваний и проведения мероприятий по формированию здорового образа жизни в медицинских организациях: Приказ МЗ РФ от 30.09.2015 № 683Н. [On approval of the procedure for organizing and implementing the prevention of non-communicable diseases and implementing measures to promote a healthy lifestyle in medical organizations: Order of the Ministry of health of the Russian Federation of September 30, 2015, No. 683N]. URL: https://normativ.kontur.ru/document?moduleId=1&documentId=369340 (04.07.2024)
Семериков В.В., Якобюк Н.О., Софронова Л.В., Юминова Н.В., Воробьева Н.Н., Контаров Н.А. Профилактическая эффективность, безопасность, иммуногенная активность и оценка уровня поствакцинальных реакций после иммунизации комбинированной тривакциной Вактривир (корь-краснуха-паротит) детей, родившихся недоношенными // Педиатрическая фармакология. 2024. Т. 21, № 2. С .90–101. [Semerikov V.V., Yakobyuk N.O., Sofronova L.V., Yuminova N.V., Vorobyeva N.N., Kontarov N.A. Preventive efficacy, safety, immunogenic activity and assessment of the level of post-vaccination reactions after immunization with the combined trivaccine Vactrivir (measles-rubella-mumps) of children born prematurely. Pediatricheskaya farmakologiya = Pediatric Pharmacology, 2024, vol. 21, no. 2, pp. 90–101. (In Russ.)] doi: 10.15690/pf.v21i2.2744
Топтыгина А.П., Клыкова Т.Г., Смердова М.А., Зеткин А.Ю. Оценка напряженности популяционного иммунитета к вирусам кори, краснухи, эпидемического паротита и ветряной оспы у здоровых взрослых // Русский медицинский журнал. 2019. № 3. С. 36–39. [Toptygina A.P., Klykova T.G., Smerdova M.A., Zetkin A.Y. Assessment of the intensity of collective immunity to measles, rubella, mumps and chickenpox viruses in healthy adults. Russkii meditsinskii zhurnal = Russian Medical Journal, 2019, no. 3, pp. 36–39. (In Russ.)]
Топтыгина А.П., Смердова М.А., Наумова М.А., Владимирова Н.П., Мамаева Т.А. Влияние особенностей популяционного иммунитета на структуру заболеваемости корью и краснухой // Инфекция и иммунитет. 2018. Т. 8, № 3. С. 341–348. [Toptygina A.P., Smerdova M.A., Naumova M.A., Vladimirova N.P., Mamaeva T.A. Influence of population immunity peculiarities on the structure of measles and rubella prevalence. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2018, vol. 8, no. 3, pp. 341–348. (In Russ.)] doi: 10.15789/2220-7619-2018-3-341-348.
Фельдблюм И.В., Романенко В.В., Субботина К.А., Меньшикова М.Г., Окунева И.А., Мусихина А.Ю., Снитковская Т.Э., Маркович Н.И., Ершов А.Е., Трофимов Д.М. Безопасность и иммунологическая эффективность отечественной комбинированной тривакцины для профилактики кори, краснухи и эпидемического паротита Вактривир® при иммунизации детей 12 месяцев и 6 лет (результаты простого слепого мультицентрового сравнительного рандомизированного клинического исследования) // Эпидемиология и вакцинопрофилактика. 2021. Т. 20, № 1. С. 32–43. [Feldblium I.V., Romanenko V.V., Subbotina K.A., Menshikova M.G., Okuneva I.A., Musikhina A.Yu., Snitkovskaya T.E., Markovich N.I., Ershov A.E., Trofimov D.M. Safety and immunological efficacy of the domestic combined trivalent vaccine for the prevention of measles, rubella and mumps Vactrivir® in immunization of children aged 12 months and 6 years (results of a single-blind multicenter comparative randomized clinical trial). Epidemiologiya i vaktsinoprofilaktika = Epidemiology and Vaccine Prophylaxis, 2021, vol. 20, no. 1, pp. 32–43. (In Russ.)] doi: 10.31631/2073-3046-2021-20-1-32-43
Цвиркун О.В., Самойлович Е.О., Тихонова Н.Т., Герасимова А.Г., Тураева Н.В., Ермолович М.А., Семейко Г.В. Cопоставление результатов исследования состояния популяционного иммунитета к вирусу краснухи у населения Республики Беларусь и Российской Федерации // Инфекция и иммунитет. 2022. Т. 12, № 5. C. 909–918. [Tsvirkun O.V., Samoilovich E.O., Tikhonova N.T., Gerasimova A.G., Turaeva N.V., Ermolovich M.A., Semeiko G.V. State of anti-rubella virus population immunity in the Republic of Belarus and Russian Federation. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2022, vol. 12, no. 5, pp. 909–918. (In Russ.)] doi: 10.15789/2220-7619-COT-1832
Цвиркун О.В., Тихонова Н.Т., Тураева Н.В., Ежлова Е.Б., Мельникова А.А., Герасимова А.Г. Характеристика популяционного иммунитета к кори в Российской Федерации // Эпидемиология и вакцинопрофилактика. 2020. Т. 19, № 4. С. 6–13. [Tsvirkun O.V., Tikhonova N.T., Turaeva N.V., Ezhlova E.B., Melnikova A.A., Gerasimova A.G. Characteristics of population immunity to measles in the Russian Federation. Epidemiologiya i vaktsinoprofilaktika = Epidemiology and Vaccine Prophylaxis, 2020, vol. 19, no. 4, pp. 6–13. (In Russ.)] doi: 10.31631/2073-3046-2020-19-4-6-13
Эпидемический паротит. Современные представления о возбудителе, клиника, диагностика, профилактика / Под ред. А.П. Агафонова. Новосибирск: ЗАО Медикобиологический Союз, 2007. 82 с. [Mumps. Modern understanding of the pathogen, clinical features, diagnostics, prevention. Ed. A.P. Agafonov. Novosibirsk: ZAO Medikobiologichesky Soyuz, 2007. 82 p. (In Russ.)]
Agresti A., Coull B.A. Approximate is better than “exact” for interval estimation of binomial proportions. Am. Stat., 1998, vol. 52, no. 2, pp. 119–126. doi: 10.2307/2685469
Almansour I. Mumps vaccines: current challenges and future prospects. Front. Microbiol., 2020, vol. 11: 1999. doi: 10.3389/fmicb.2020.01999
Banerjee A., Suthar R., Vyas S., Singh M.P. Acute disseminated encephalomyelitis: complication of a vaccine preventable disease. BMJ Case Rep., 2018, vol. 11, no. 1: e225710. doi: 10.1136/bcr-2018-225710
Bankamp B., Hickman C., Icenogle J.P., Rota P.A. Successes and challenges for preventing measles, mumps and rubella by vaccination. Curr. Opin. Virol., 2019, no. 34, pp. 110–116. doi: 10.1016/j.coviro.2019.01.002
Bukasa A., Campbell H., Brown K., Bedford H., Ramsay M., Amirthalingam G., Tookey P. Rubella infection in pregnancy and congenital rubella in United Kingdom, 2003 to 2016. Euro Surveill., 2018, vol. 23, no. 19: 17-00381. doi: 10.2807/1560-7917.ES.2018.23.19.17-0038
Connell A.R., Connell J., Leahy T.R., Hassan J. Mumps outbreaks in vaccinated populations — is it time to re-assess the clinical efficacy of vaccines? Front. Immunol., 2020, no. 11: 2089. doi: 10.3389/fimmu.2020.02089
Coughlin M.M., Beck A.S., Bankamp B., Rota P.A. Perspective on global measles epidemiology and control and the role of novel vaccination strategies. Viruses, 2017, vol. 9, no. 1: 11. doi: 10.3390/v9010011
Dassarma B., Tripathy S., Chabalala M., Matsabisa M.G. Challenges in establishing vaccine induced herd immunity through age specific community vaccinations. Aging. Dis., 2022, vol. 13, no. 1, pp. 29–36. doi: 10.14336/AD.2021.0611
Furuse Y. Oshitani H. Global transmission dynamics of measles in the measles elimination era. Viruses, 2017, vol. 9, no. 4: 82. doi: 10.3390/v9040082
Galazka A.M., Robertson S.E., Kraigher A. Mumps and mumps vaccine: a global review. Bull. World Health Organ., 1999, vol. 77, no. 1, p 3–14. PMC2557572
George S.,Viswanathan R., Sapkal G.N. Molecular aspects of the teratogenesis of rubella virus. Biol. Res., 2019, no. 52: 47. doi: 10.1186/s40659-019-0254-3
Gokhale D.V., Brett T.S., He B., King A.A., Rohani P. Disentangling the causes of mumps reemergence in the United States. Proc. Natl Acad. Sci. USA, 2023, vol. 120, no. 3: e2207595120. doi: 10.1073/pnas.2207595120
Griffin D.E., Lin W.H., Pan C.H. Measles virus, immune control, and persistence. FEMS Microbiol. Rev., 2012, vol. 36, no. 3, pp. 649–662. doi: 10.1111/j.1574-6976.2012.00330.x
Gupta R.K., Best J., MacMahon E. Mumps and the UK epidemic 2005. BMJ, 2005, no. 330: 1132. doi: 10.1136/bmj.330.7500.1132
Kuter B.J., Marshall G.S., Fergie J., Schmidt E., Pawaskar M. Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII. Hum. Vaccin. Immunother., 2021, vol. 17, no. 12, pp. 5372–5383. doi: 10.1080/21645515.2021.2007710
Lahariya C. Vaccine epidemiology: a review. J. Family Med. Prim. Care., 2016, vol. 5, no. 1, pp. 7–15. doi: 10.4103/2249-4863.184616
Lambert N., Strebel P., Orenstein W., Icenogle J., Poland G.A. Rubella. Lancet, 2015, vol. 385, no. 9984, pp. 2297–2307. doi: 10.1016/S0140-6736(14)60539-0
Law K.В., Peariasamy K.M., Ibrahim H.M., Abdullah N.H. Modelling infectious diseases with herd immunity in a randomly mixed population. Sci. Rep., 2021, no. 11: 20574. doi: 10.1038/s41598-021-00013-2
Lievano F., Galea S.A., Thornton M., Wiedmann R.T., Manoff S.B., Tran T.N., Amin M.A., Seminack M.M., Vagie K.A., Dana A., Plotkin S.A. Measles, mumps, and rubella virus vaccine (M-M-R™II): a review of 32 years of clinical and postmarketing experience. Vaccine, 2012, vol. 30, no. 48, pp. 6918–6926. doi: 10.1016/j.vaccine.2012.08.057
Mawson A.R., Croft A.M. Rubella virus infection, the congenital rubella syndrome, and the link to autism. Int. J. Environ. Res. Public Health, 2019, vol. 16, no. 19: 3543. doi: 10.3390/ijerph16193543
Montalbán A., Corder R.M., Gomes M.G.M. Herd immunity under individual variation and reinfection. J. Math. Biol., 2022, vol. 85, no. 1: 2. doi: 10.1007/s00285-022-01771-x
Nabarro L., Morris-Jones S., Moore D.A.J. Infections acquired by airborne transmission. Peter’s Atlas of Tropical Medicine and Parasitology, 2020, pp. 244–281. doi: 10.1016/B978-0-7020-4061-0.00004-2
Ohfuji S., Takagi A., Nakano T., Kumihashi H., Kano M., Tanaka T. Mumps-related disease burden in Japan: analysis of JMDC health insurance reimbursement data for 2005–2017. J. Epidemiol., 2021, vol. 31, no. 8, pp. 464–470. doi: 10.2188/jea.JE20200048
Otshudiema J.O., Acosta A.M., Cassiday P.K., Hadler S.C., Hariri S., Tiwari T.S. P. Respiratory illness caused by Corynebacterium diphtheriae and C. ulcerans, and use of diphtheria antitoxin in the United States, 1996–2018. Clin. Infect. Dis., 2021, vol. 73, no. 9, pp. e2799–e2806. doi: 10.1093/cid/ciaa1218.
Our World in Data. URL: https://ourworldindata.org (27.04.2024)
Parkman P.D., Meyer H.M. Jr. Prospects for a rubella virus vaccine. Prog. Med. Virol. 1969, vol. 11, pp. 80–106.
Papadopoulos T., Vynnycky E. Estimates of the basic reproduction number for rubella using seroprevalence data and indicator-based approaches. PLoS Comput Biol., 2022, vol. 18, no. 3: e1008858. doi: 10.1371/journal.pcbi.1008858
Piret J., Boivin G. Pandemics throughout history updated. Front. Microbiol., 2022, no. 13: 988058. doi: 10.3389/fmicb.2020.63173
Plans P. New preventive strategy to eliminate measles, mumps and rubella from Europe based on the serological assessment of herd immunity levels in the population. Eur. J. Clin. Microbiol. Infect. Dis., 2013, vol. 32, no. 7, pp. 961–966. doi: 10.1007/s10096-013-1836-6
Plans-Rubió, P. Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage. Human Vaccines & Immunotherapeutics, 2012, vol. 8, no. 2, pp. 184–188. doi: 10.4161/hv.18444
Pollard A.J., Bijker E.M. A guide to vaccinology: from basic principles to new developments. Nat. Rev. Immunol., 2021, vol. 21, no. 2, pp. 83–100. doi: 10.1038/s41577-020-00479-7
Public Health Agency of Canada, Vaccination Coverage Goals and Vaccine Preventable Disease Reduction Targets by 2025. URL: https://www.canada.ca/en/public-health/services/immunization-vaccine-priorities/national-immunization-strategy/vaccination-coverage-goals-vaccine-preventable-diseases-reduction-targets-2025.html#1.1.3 (19.05.2024)
Robinson J. Pandemics. URL: https://www.webmd.com/cold-and-flu/what-are-epidemics-pandemics-outbreaks (27.04.2024)
Rozhnova G., Metcalf C.J.E., Grenfell B.T. Characterizing the dynamics of rubella relative to measles: the role of stochasticity. J. R. Soc. Interface, 2013, vol. 10, no. 88: 20130643. doi: 10.1098/rsif.2013.0643
Schenk J., Abrams S., Theeten, H. Van Damme P., Beutels P., Hens N. Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis. Lancet Infect. Dis., 2021, vol. 21, no. 2, pp. 286–295. doi: 10.1016/S1473-3099(20)30442-4
Shah N., Ghosh A., Kumar K., Dutta T., Mahajan M. A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine. Hum. Vaccin. Immunother., 2024, vol. 20, no. 1: 2302685. doi: 10.1080/21645515.2024.2302685
Su Q., Feng Z., Hao L., Ma C., Hagan J. E, Grant G. B, Wen N., Fan C., Yang H., Rodewald L. E, Wang H., Glasser J.W. Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a meta-population modeling study. Lancet Infect. Dis., 2021, vol. 21, no. 7, pp. 1004–1013. doi: 10.1016/S1473-3099(20)30475-8
Su S.B., Chang H.L., Chen A.K. Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine. Int. J. Environ. Res. Public Health, 2020, vol. 17, no. 5: 1686. doi: 10.3390/ijerph17051686
Thompson K.M. Evolution and use of dynamic transmission models for measles and rubella risk and policy analysis. Risk Anal., 2016, vol. 36, no. 7, pp. 383–1403. doi: 10.1111/risa.12637
Trabert B., Graubard B.I., Erickson R.L., McGlynn K.A. Childhood infections, orchitis and testicular germ cell tumours: a report from the STEED study and a meta-analysis of existing data. Br. J. Cancer, 2012, vol. 106, no. 7, pp. 1331–1334. doi: 10.1038/bjc.2012.45
Trainor E.A., Nicholson T.L., Merkel T.J. Bordetella pertussis transmission. Pathog. Dis., 2015, vol. 73, no. 8: ftv068. doi: 10.1093/femspd/ftv068
Van der Kuyl A.C. Historic and prehistoric epidemics: an overview of sources available for the study of ancient pathogens. Epidemiologia (Basel), 2022, vol. 3, no. 4, pp. 443–464. doi: 10.3390/epidemiologia3040034
Wald A., Wolfowitz J. Confidence limits for continuous distribution functions. Ann. Math. Statist., 1939, vol. 10, no. 2, pp. 105–118. URL: www.jstor.org/stable/2235689 (10.07.2021)
Wang C.C., Prather K.A., Sznitman J., Jimenez J.L., Lakdawala S.S., Tufekci Z., Marr L.C. Airborne transmission of respiratory viruses. Science, 2021, vol. 373, no. 6558: eabd9149. doi: 10.1126/science.abd9149
Wang Z., Yan R., He H., Li Q., Chen G., Yang S., Chen E. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination. PLoS One, 2014, vol. 9, no. 2: e89361. doi: 10.1371/journal.pone.0089361
World Health Organization. Coronavirus (COVID-19). URL: data.who.int/covid19/cases (06.04.2024)
Wu H., Wang F., Tang D., Han D. Mumps orchitis: clinical aspects and mechanisms. Front. Immunol., 2021, no. 12: 582946. doi: 10.3389/fimmu.2021.582946
Yadegari I., Omidi M., Smith S.R. The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants. Sci. Rep., 2021, vol. 11, no. 22970. doi: 10.1038/s41598-021-00083-2
Yoo J.W., Tae B.S., Chang H.K., Song M.S., Cheon J., Park J.Y., Bae J.H. Epidemiology of mumps, mumps complications, and mumps orchitis in Korea using the National Health Insurance Service database. Investig. Clin. Urol., 2023, vol. 64, no. 4, pp. 412–417. doi: 10.4111/icu.20230064
Yung C.F., Ramsay M. Estimating true hospital morbidity of complications associated with mumps outbreak, England, 2004/05. Euro Surveill., 2016, vol. 21, no. 33: 30320. doi: 10.2807/1560-7917
Zhao X., Liu S., Yin Y., Zhang T.T., Chen Q. Airborne transmission of COVID-19 virus in enclosed spaces: an overview of research methods. Indoor Air, 2022, vol. 32, no. 6: e13056. doi: 10.1111/ina.13056

补充文件

附件文件

动作

1. JATS XML

下载

2. Figure 1. Annual incidence dynamics of measles, mumps, and rubella in the St. Petersburg population (2010 to 2023)

下载 (224KB)

用户名
密码
记住我

忘记您的密码?	注册

用户名
密码
记住我

忘记您的密码?	注册